nifedipine has been researched along with Familial Hyperinsulinemic Hypoglycemia 1 in 9 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral nifedipine has been effective in isolated cases of CHI." | 5.42 | Nifedipine in Congenital Hyperinsulinism - A Case Report. ( Basak, D; Chatterjee, S; Flanagan, SE; Hussain, K; Khawash, P, 2015) |
| "We report a newborn infant with persistent hyperinsulinemic hypoglycemia whom we successfully treated with oral nifedipine alone after surgical therapies." | 5.39 | Treatment of hyperinsulinemic hypoglycemia because of diffuse nesidioblastosis with nifedipine after surgical therapies in a newborn. ( Keskin, M; Koklu, E; Koklu, S; Ozkan, KU; Sayar, H, 2013) |
| "Nifedipine was administered orally at an escalating dose up to a maximum of 2." | 1.46 | Assessment of Nifedipine Therapy in Hyperinsulinemic Hypoglycemia due to Mutations in the ABCC8 Gene. ( Gilbert, C; Güemes, M; Hinchey, L; Hussain, K; Morgan, K; Shah, P; Silvera, S, 2017) |
| "Oral nifedipine has been effective in isolated cases of CHI." | 1.42 | Nifedipine in Congenital Hyperinsulinism - A Case Report. ( Basak, D; Chatterjee, S; Flanagan, SE; Hussain, K; Khawash, P, 2015) |
| " Whilst our patient responded well to nifedipine, the dosage could not be increased to 0." | 1.40 | A combination of nifedipine and octreotide treatment in an hyperinsulinemic hypoglycemic infant. ( Akcurin, S; Bircan, I; Durmaz, E; Ellard, S; Flanagan, SE; Parlak, M, 2014) |
| "We report a newborn infant with persistent hyperinsulinemic hypoglycemia whom we successfully treated with oral nifedipine alone after surgical therapies." | 1.39 | Treatment of hyperinsulinemic hypoglycemia because of diffuse nesidioblastosis with nifedipine after surgical therapies in a newborn. ( Keskin, M; Koklu, E; Koklu, S; Ozkan, KU; Sayar, H, 2013) |
| "EEG revealed the typical pattern of hypsarrhythmia leading to the diagnosis of West syndrome." | 1.32 | Persistent hyperinsulinemic hypoglycemia presenting with a rare complication: West syndrome. ( Bideci, A; Camurdan, MO; Cinaz, P; Demirel, F; Serdaroğlu, A, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, D | 1 |
| Liu, H | 1 |
| Ruzi, A | 1 |
| Gao, G | 1 |
| Nasir, A | 1 |
| Liu, Y | 1 |
| Yang, F | 1 |
| Wu, F | 1 |
| Xu, G | 1 |
| Li, YX | 1 |
| Koklu, E | 1 |
| Ozkan, KU | 1 |
| Sayar, H | 1 |
| Koklu, S | 1 |
| Keskin, M | 1 |
| Durmaz, E | 1 |
| Flanagan, SE | 2 |
| Parlak, M | 1 |
| Ellard, S | 1 |
| Akcurin, S | 1 |
| Bircan, I | 1 |
| Kim, MS | 1 |
| Kong, YH | 1 |
| Lee, DY | 1 |
| Khawash, P | 1 |
| Hussain, K | 3 |
| Chatterjee, S | 1 |
| Basak, D | 1 |
| Güemes, M | 1 |
| Shah, P | 1 |
| Silvera, S | 1 |
| Morgan, K | 1 |
| Gilbert, C | 1 |
| Hinchey, L | 1 |
| Müller, D | 1 |
| Zimmering, M | 1 |
| Roehr, CC | 1 |
| Camurdan, MO | 1 |
| Cinaz, P | 1 |
| Serdaroğlu, A | 1 |
| Bideci, A | 1 |
| Demirel, F | 1 |
| Aynsley-Green, A | 1 |
| Stanley, CA | 1 |
2 reviews available for nifedipine and Familial Hyperinsulinemic Hypoglycemia 1
| Article | Year |
|---|---|
Should nifedipine be used to counter low blood sugar levels in children with persistent hyperinsulinaemic hypoglycaemia?
Topics: Adolescent; Calcium Channel Blockers; Child; Child, Preschool; Congenital Hyperinsulinism; Humans; I | 2004 |
Medications used in the treatment of hypoglycemia due to congenital hyperinsulinism of infancy (HI).
Topics: Congenital Hyperinsulinism; Diazoxide; Gastrointestinal Agents; Glucagon; Humans; Hypoglycemia; Infa | 2004 |
7 other studies available for nifedipine and Familial Hyperinsulinemic Hypoglycemia 1
| Article | Year |
|---|---|
Modeling Congenital Hyperinsulinism with ABCC8-Deficient Human Embryonic Stem Cells Generated by CRISPR/Cas9.
Topics: C-Peptide; Cell Differentiation; Congenital Hyperinsulinism; CRISPR-Cas Systems; Gastrointestinal Ag | 2017 |
Treatment of hyperinsulinemic hypoglycemia because of diffuse nesidioblastosis with nifedipine after surgical therapies in a newborn.
Topics: Combined Modality Therapy; Congenital Hyperinsulinism; Humans; Infant, Newborn; Male; Nesidioblastos | 2013 |
A combination of nifedipine and octreotide treatment in an hyperinsulinemic hypoglycemic infant.
Topics: Child, Preschool; Codon, Nonsense; Congenital Hyperinsulinism; Diazoxide; Humans; Infant; Infant, Ne | 2014 |
A Case of Subclinical Hypothyroidism with Lingual and Right Pretracheal Ectopic Thyroid.
Topics: Blood Glucose; C-Peptide; Calcium Channel Blockers; Choristoma; Codon, Nonsense; Congenital Hyperins | 2015 |
Nifedipine in Congenital Hyperinsulinism - A Case Report.
Topics: Blood Glucose; C-Peptide; Calcium Channel Blockers; Codon, Nonsense; Congenital Hyperinsulinism; Dia | 2015 |
Assessment of Nifedipine Therapy in Hyperinsulinemic Hypoglycemia due to Mutations in the ABCC8 Gene.
Topics: Calcium Channel Blockers; Child, Preschool; Cohort Studies; Congenital Hyperinsulinism; Diazoxide; D | 2017 |
Persistent hyperinsulinemic hypoglycemia presenting with a rare complication: West syndrome.
Topics: Adrenocorticotropic Hormone; Anticonvulsants; Congenital Hyperinsulinism; Diazoxide; Electroencephal | 2004 |